NCT06304740View on ClinicalTrials.gov

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

August 28, 2024

Study Completion Date

August 28, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

IMG-007

Subcutaneous injection of IMG-007

DRUG

Placebo

Subcutaneous Injection of Placebo

Trial Locations (1)

Unknown

Linear Clinical Research, Perth

Sponsors

Lead Sponsor

Inmagene LLC
All Listed Sponsors
lead

Inmagene LLC

INDUSTRY

NCT06304740 - Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants | Biotech Hunter | Biotech Hunter